•  
  •  
  •  
  •  

2025-10-08 04:34:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss

Keywords Selected:  Commercialization

Stock Report

  • Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
  • Ion Exchange India Ltd commences stage-wise commissioning of Greenfield Resin manufacturing plant
  • Lupin Ltd enters into agreement with Zentiva for biosimilar Certolizumab Pegol
  • BPCL Mumbai Refinery Inaugurates the Commercial Use of Indigenous FCC Bottoms Cracking Additive "BHARAT BCA"
  • Lupin Enters into a Non-Exclusive Patent Licensing Agreement with Takeda to Commercialize Vonoprazan, a Novel Gastrointestinal Drug in India
  • Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
  • Clean Science and Technology Ltd commissions new plant to manufacture HALS
  • SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma

Latest Post

  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024